These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 22670609)

  • 1. Recent patents in siRNA delivery employing nanoparticles as delivery vectors.
    Nimesh S
    Recent Pat DNA Gene Seq; 2012 Aug; 6(2):91-7. PubMed ID: 22670609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategies and advances in nanomedicine for targeted siRNA delivery.
    Nimesh S; Gupta N; Chandra R
    Nanomedicine (Lond); 2011 Jun; 6(4):729-46. PubMed ID: 21718181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimized polyethylenimine (PEI)-based nanoparticles for siRNA delivery, analyzed in vitro and in an ex vivo tumor tissue slice culture model.
    Ewe A; Höbel S; Heine C; Merz L; Kallendrusch S; Bechmann I; Merz F; Franke H; Aigner A
    Drug Deliv Transl Res; 2017 Apr; 7(2):206-216. PubMed ID: 27334279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid-based nanoparticles in the systemic delivery of siRNA.
    Lin Q; Chen J; Zhang Z; Zheng G
    Nanomedicine (Lond); 2014 Jan; 9(1):105-20. PubMed ID: 24354813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of disulfide-bridge on the activities of H-shape gemini-like cationic lipid based siRNA delivery.
    Ma XF; Sun J; Qiu C; Wu YF; Zheng Y; Yu MZ; Pei XW; Wei L; Niu YJ; Pang WH; Yang ZJ; Wang JC; Zhang Q
    J Control Release; 2016 Aug; 235():99-111. PubMed ID: 27242198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cationic lipids and polymers mediated vectors for delivery of siRNA.
    Zhang S; Zhao B; Jiang H; Wang B; Ma B
    J Control Release; 2007 Oct; 123(1):1-10. PubMed ID: 17716771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymers in small-interfering RNA delivery.
    Singha K; Namgung R; Kim WJ
    Nucleic Acid Ther; 2011 Jun; 21(3):133-47. PubMed ID: 21749290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poly(glycerol methacrylate)-based degradable nanoparticles for delivery of small interfering RNA.
    Morsi NG; Ali SM; Elsonbaty SS; Afifi AA; Hamad MA; Gao H; Elsabahy M
    Pharm Dev Technol; 2018 Apr; 23(4):387-399. PubMed ID: 28347210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cationic Lipid-Coated Polyplexes (Lipopolyplexes) for DNA and Small RNA Delivery.
    Ewe A; Aigner A
    Methods Mol Biol; 2016; 1445():187-200. PubMed ID: 27436320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and characterization of Fe
    Arami S; Rashidi MR; Mahdavi M; Fathi M; Entezami AA
    Hum Exp Toxicol; 2017 Mar; 36(3):227-237. PubMed ID: 27162247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid and Polymer-Based Nanoparticle siRNA Delivery Systems for Cancer Therapy.
    Mainini F; Eccles MR
    Molecules; 2020 Jun; 25(11):. PubMed ID: 32532030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chitosan nanoparticles for siRNA delivery: optimizing formulation to increase stability and efficiency.
    Ragelle H; Riva R; Vandermeulen G; Naeye B; Pourcelle V; Le Duff CS; D'Haese C; Nysten B; Braeckmans K; De Smedt SC; Jérôme C; Préat V
    J Control Release; 2014 Feb; 176():54-63. PubMed ID: 24389132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-step assembly of cationic lipid-polymer hybrid nanoparticles for systemic delivery of siRNA.
    Yang XZ; Dou S; Wang YC; Long HY; Xiong MH; Mao CQ; Yao YD; Wang J
    ACS Nano; 2012 Jun; 6(6):4955-65. PubMed ID: 22646867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanotechnology for in vivo targeted siRNA delivery.
    Dahlman JE; Kauffman KJ; Langer R; Anderson DG
    Adv Genet; 2014; 88():37-69. PubMed ID: 25409603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid-based nanoparticles for siRNA delivery in cancer therapy: paradigms and challenges.
    Gomes-da-Silva LC; Fonseca NA; Moura V; Pedroso de Lima MC; Simões S; Moreira JN
    Acc Chem Res; 2012 Jul; 45(7):1163-71. PubMed ID: 22568781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-homing glycol chitosan/polyethylenimine nanoparticles for the systemic delivery of siRNA in tumor-bearing mice.
    Huh MS; Lee SY; Park S; Lee S; Chung H; Lee S; Choi Y; Oh YK; Park JH; Jeong SY; Choi K; Kim K; Kwon IC
    J Control Release; 2010 Jun; 144(2):134-43. PubMed ID: 20184928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel biotinylated chitosan-graft-polyethyleneimine copolymer as a targeted non-viral vector for anti-EGF receptor siRNA delivery in cancer cells.
    Darvishi MH; Nomani A; Amini M; Shokrgozar MA; Dinarvand R
    Int J Pharm; 2013 Nov; 456(2):408-16. PubMed ID: 24012865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid nanoparticles as vehicles for macromolecules: nucleic acids and peptides.
    del Pozo-Rodríguez A; Delgado D; Solinís MA; Gascón AR
    Recent Pat Drug Deliv Formul; 2011 Sep; 5(3):214-26. PubMed ID: 21834776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced siRNA delivery using cationic liposomes with new polyarginine-conjugated PEG-lipid.
    Kim HK; Davaa E; Myung CS; Park JS
    Int J Pharm; 2010 Jun; 392(1-2):141-7. PubMed ID: 20347025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. siRNA delivery by a transferrin-associated lipid-based vector: a non-viral strategy to mediate gene silencing.
    Cardoso AL; Simões S; de Almeida LP; Pelisek J; Culmsee C; Wagner E; Pedroso de Lima MC
    J Gene Med; 2007 Mar; 9(3):170-83. PubMed ID: 17351968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.